A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer
Clinical trial NCT06532331 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06532331
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2027-09-30
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.